HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-MAR-12 4E28 TITLE STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE IN INACTIVE CONFORMATION WITH TITLE 2 A NOVEL NON-PEPTIDIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 26-311; COMPND 5 SYNONYM: TS, TSASE; COMPND 6 EC: 2.1.1.45; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYMS, TS, OK/SW-CL.29; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HUMAN THYMIDYLATE SYNTHASE (HTS) INACTIVE CONFORMATION, HTS-INHIBITOR KEYWDS 2 COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.TOCHOWICZ,J.FINER-MOORE,R.M.STROUD,M.P.COSTI REVDAT 4 13-SEP-23 4E28 1 REMARK SEQADV LINK REVDAT 3 15-NOV-17 4E28 1 REMARK REVDAT 2 12-DEC-12 4E28 1 JRNL REVDAT 1 14-NOV-12 4E28 0 JRNL AUTH E.CAROSATI,A.TOCHOWICZ,G.MARVERTI,G.GUAITOLI,P.BENEDETTI, JRNL AUTH 2 S.FERRARI,R.M.STROUD,J.FINER-MOORE,R.LUCIANI,D.FARINA, JRNL AUTH 3 G.CRUCIANI,M.P.COSTI JRNL TITL INHIBITOR OF OVARIAN CANCER CELLS GROWTH BY VIRTUAL JRNL TITL 2 SCREENING: A NEW THIAZOLE DERIVATIVE TARGETING HUMAN JRNL TITL 3 THYMIDYLATE SYNTHASE. JRNL REF J.MED.CHEM. V. 55 10272 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 23075414 JRNL DOI 10.1021/JM300850V REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.2_869 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 18948 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 973 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.2278 - 4.3996 0.84 2366 122 0.2020 0.2258 REMARK 3 2 4.3996 - 3.4940 0.91 2445 142 0.1784 0.2120 REMARK 3 3 3.4940 - 3.0528 0.99 2635 145 0.1830 0.2341 REMARK 3 4 3.0528 - 2.7739 1.00 2651 141 0.1818 0.2356 REMARK 3 5 2.7739 - 2.5753 1.00 2627 134 0.1741 0.2542 REMARK 3 6 2.5753 - 2.4235 1.00 2650 141 0.1804 0.2045 REMARK 3 7 2.4235 - 2.3022 1.00 2601 148 0.2288 0.3032 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 67.93 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.590 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.14500 REMARK 3 B22 (A**2) : -0.14500 REMARK 3 B33 (A**2) : 0.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2167 REMARK 3 ANGLE : 1.246 2932 REMARK 3 CHIRALITY : 0.079 305 REMARK 3 PLANARITY : 0.005 373 REMARK 3 DIHEDRAL : 18.520 813 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 50.4411 -8.1320 16.1033 REMARK 3 T TENSOR REMARK 3 T11: 0.3214 T22: 0.1741 REMARK 3 T33: 0.2558 T12: 0.0484 REMARK 3 T13: -0.0448 T23: -0.0227 REMARK 3 L TENSOR REMARK 3 L11: 1.0134 L22: 1.9885 REMARK 3 L33: 1.4625 L12: -0.6846 REMARK 3 L13: 0.2006 L23: 0.4414 REMARK 3 S TENSOR REMARK 3 S11: 0.2217 S12: 0.1197 S13: -0.2244 REMARK 3 S21: -0.2258 S22: -0.0950 S23: 0.1052 REMARK 3 S31: 0.0740 S32: -0.0802 S33: 0.0017 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4E28 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1000071076. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 273 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11588 REMARK 200 MONOCHROMATOR : KHOZU DOUBLE FLAT CRYSTAL REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18949 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : 0.10200 REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1HVY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M AMMONIUM SULFATE, 20 UM BME, 0.1 REMARK 280 M TRIS, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 273K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.46900 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.93800 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 54.93800 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.46900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -80.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 54.93800 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -11 REMARK 465 ARG A -10 REMARK 465 GLY A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 VAL A 3 REMARK 465 ALA A 4 REMARK 465 GLY A 5 REMARK 465 SER A 6 REMARK 465 GLU A 7 REMARK 465 LEU A 8 REMARK 465 PRO A 9 REMARK 465 ARG A 10 REMARK 465 ARG A 11 REMARK 465 PRO A 12 REMARK 465 LEU A 13 REMARK 465 PRO A 14 REMARK 465 PRO A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 GLN A 18 REMARK 465 GLU A 19 REMARK 465 ARG A 20 REMARK 465 ASP A 21 REMARK 465 ALA A 22 REMARK 465 GLU A 23 REMARK 465 PRO A 24 REMARK 465 ARG A 25 REMARK 465 GLY A 105 REMARK 465 VAL A 106 REMARK 465 LYS A 107 REMARK 465 ILE A 108 REMARK 465 TRP A 109 REMARK 465 ASP A 110 REMARK 465 ALA A 111 REMARK 465 ASN A 112 REMARK 465 GLY A 113 REMARK 465 SER A 114 REMARK 465 ARG A 115 REMARK 465 ASP A 116 REMARK 465 PHE A 117 REMARK 465 LEU A 118 REMARK 465 ASP A 119 REMARK 465 SER A 120 REMARK 465 LEU A 121 REMARK 465 GLY A 122 REMARK 465 PHE A 123 REMARK 465 SER A 124 REMARK 465 THR A 125 REMARK 465 ARG A 126 REMARK 465 GLU A 127 REMARK 465 GLU A 128 REMARK 465 GLY A 129 REMARK 465 GLY A 143 REMARK 465 ALA A 144 REMARK 465 GLU A 145 REMARK 465 TYR A 146 REMARK 465 ARG A 147 REMARK 465 ASP A 148 REMARK 465 MET A 149 REMARK 465 GLU A 150 REMARK 465 SER A 151 REMARK 465 ASP A 152 REMARK 465 ALA A 312 REMARK 465 VAL A 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 100 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS A 141 O HOH A 569 1.94 REMARK 500 NH1 ARG A 283 O HOH A 526 2.11 REMARK 500 N THR A 53 O HOH A 524 2.16 REMARK 500 N GLY A 54 O HOH A 524 2.17 REMARK 500 O HOH A 550 O HOH A 565 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 199 CB CYS A 199 SG -0.103 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 101 60.74 -109.12 REMARK 500 SER A 154 40.56 -63.15 REMARK 500 ASN A 171 76.04 -157.83 REMARK 500 SER A 206 17.14 59.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0MZ A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9MZ A 404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3EGY RELATED DB: PDB REMARK 900 RELATED ID: 3EHI RELATED DB: PDB DBREF 4E28 A 1 313 UNP P04818 TYSY_HUMAN 1 313 SEQADV 4E28 MET A -11 UNP P04818 EXPRESSION TAG SEQADV 4E28 ARG A -10 UNP P04818 EXPRESSION TAG SEQADV 4E28 GLY A -9 UNP P04818 EXPRESSION TAG SEQADV 4E28 SER A -8 UNP P04818 EXPRESSION TAG SEQADV 4E28 HIS A -7 UNP P04818 EXPRESSION TAG SEQADV 4E28 HIS A -6 UNP P04818 EXPRESSION TAG SEQADV 4E28 HIS A -5 UNP P04818 EXPRESSION TAG SEQADV 4E28 HIS A -4 UNP P04818 EXPRESSION TAG SEQADV 4E28 HIS A -3 UNP P04818 EXPRESSION TAG SEQADV 4E28 HIS A -2 UNP P04818 EXPRESSION TAG SEQADV 4E28 GLY A -1 UNP P04818 EXPRESSION TAG SEQADV 4E28 SER A 0 UNP P04818 EXPRESSION TAG SEQRES 1 A 325 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 A 325 PRO VAL ALA GLY SER GLU LEU PRO ARG ARG PRO LEU PRO SEQRES 3 A 325 PRO ALA ALA GLN GLU ARG ASP ALA GLU PRO ARG PRO PRO SEQRES 4 A 325 HIS GLY GLU LEU GLN TYR LEU GLY GLN ILE GLN HIS ILE SEQRES 5 A 325 LEU ARG CYS GLY VAL ARG LYS ASP ASP ARG THR GLY THR SEQRES 6 A 325 GLY THR LEU SER VAL PHE GLY MET GLN ALA ARG TYR SER SEQRES 7 A 325 LEU ARG ASP GLU PHE PRO LEU LEU THR THR LYS ARG VAL SEQRES 8 A 325 PHE TRP LYS GLY VAL LEU GLU GLU LEU LEU TRP PHE ILE SEQRES 9 A 325 LYS GLY SER THR ASN ALA LYS GLU LEU SER SER LYS GLY SEQRES 10 A 325 VAL LYS ILE TRP ASP ALA ASN GLY SER ARG ASP PHE LEU SEQRES 11 A 325 ASP SER LEU GLY PHE SER THR ARG GLU GLU GLY ASP LEU SEQRES 12 A 325 GLY PRO VAL TYR GLY PHE GLN TRP ARG HIS PHE GLY ALA SEQRES 13 A 325 GLU TYR ARG ASP MET GLU SER ASP TYR SER GLY GLN GLY SEQRES 14 A 325 VAL ASP GLN LEU GLN ARG VAL ILE ASP THR ILE LYS THR SEQRES 15 A 325 ASN PRO ASP ASP ARG ARG ILE ILE MET CME ALA TRP ASN SEQRES 16 A 325 PRO ARG ASP LEU PRO LEU MET ALA LEU PRO PRO CME HIS SEQRES 17 A 325 ALA LEU CYS GLN PHE TYR VAL VAL ASN SER GLU LEU SER SEQRES 18 A 325 CYS GLN LEU TYR GLN ARG SER GLY ASP MET GLY LEU GLY SEQRES 19 A 325 VAL PRO PHE ASN ILE ALA SER TYR ALA LEU LEU THR TYR SEQRES 20 A 325 MET ILE ALA HIS ILE THR GLY LEU LYS PRO GLY ASP PHE SEQRES 21 A 325 ILE HIS THR LEU GLY ASP ALA HIS ILE TYR LEU ASN HIS SEQRES 22 A 325 ILE GLU PRO LEU LYS ILE GLN LEU GLN ARG GLU PRO ARG SEQRES 23 A 325 PRO PHE PRO LYS LEU ARG ILE LEU ARG LYS VAL GLU LYS SEQRES 24 A 325 ILE ASP ASP PHE LYS ALA GLU ASP PHE GLN ILE GLU GLY SEQRES 25 A 325 TYR ASN PRO HIS PRO THR ILE LYS MET GLU MET ALA VAL MODRES 4E28 CME A 180 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4E28 CME A 195 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 180 10 HET CME A 195 10 HET SO4 A 401 5 HET SO4 A 402 5 HET 0MZ A 403 44 HET 9MZ A 404 43 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM 0MZ 2-{(2Z,5S)-4-HYDROXY-2-[(2E)-(2-HYDROXYBENZYLIDENE) HETNAM 2 0MZ HYDRAZINYLIDENE]-2,5-DIHYDRO-1,3-THIAZOL-5-YL}-N-[3- HETNAM 3 0MZ (TRIFLUOROMETHYL)PHENYL]ACETAMIDE HETNAM 9MZ 2-{(5S)-2-[(2E)-2-(2-HYDROXYBENZYLIDENE)HYDRAZINYL]-4- HETNAM 2 9MZ OXO-4,5-DIHYDRO-1,3-THIAZOL-5-YL}-N-[3- HETNAM 3 9MZ (TRIFLUOROMETHYL)PHENYL]ACETAMIDE FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 0MZ C19 H15 F3 N4 O3 S FORMUL 5 9MZ C19 H15 F3 N4 O3 S FORMUL 6 HOH *92(H2 O) HELIX 1 1 GLY A 29 GLY A 44 1 16 HELIX 2 2 PHE A 80 GLY A 94 1 15 HELIX 3 3 ASN A 97 LEU A 101 5 5 HELIX 4 4 ASP A 159 ASN A 171 1 13 HELIX 5 5 ASN A 183 LEU A 187 5 5 HELIX 6 6 LEU A 221 GLY A 242 1 22 HELIX 7 7 HIS A 261 GLN A 270 1 10 HELIX 8 8 LYS A 287 PHE A 291 5 5 HELIX 9 9 LYS A 292 GLU A 294 5 3 SHEET 1 A 6 VAL A 45 LYS A 47 0 SHEET 2 A 6 THR A 55 SER A 66 -1 O SER A 57 N VAL A 45 SHEET 3 A 6 LYS A 244 TYR A 258 -1 O PHE A 248 N TYR A 65 SHEET 4 A 6 GLU A 207 ASP A 218 1 N CYS A 210 O ILE A 249 SHEET 5 A 6 ALA A 197 VAL A 204 -1 N TYR A 202 O SER A 209 SHEET 6 A 6 ILE A 178 ALA A 181 -1 N MET A 179 O CYS A 199 SHEET 1 B 2 LYS A 278 ILE A 281 0 SHEET 2 B 2 PHE A 296 GLU A 299 -1 O GLU A 299 N LYS A 278 LINK C MET A 179 N CME A 180 1555 1555 1.33 LINK C CME A 180 N ALA A 181 1555 1555 1.33 LINK C PRO A 194 N CME A 195 1555 1555 1.33 LINK C CME A 195 N HIS A 196 1555 1555 1.32 CISPEP 1 GLY A 132 PRO A 133 0 -2.01 SITE 1 AC1 7 ARG A 50 ARG A 78 ARG A 176 ARG A 185 SITE 2 AC1 7 LEU A 189 PRO A 305 THR A 306 SITE 1 AC2 4 ARG A 175 ASN A 183 ARG A 215 SER A 216 SITE 1 AC3 12 LYS A 77 ARG A 78 VAL A 79 PHE A 80 SITE 2 AC3 12 GLU A 87 LEU A 101 LYS A 104 GLY A 132 SITE 3 AC3 12 PRO A 133 GLY A 220 LEU A 221 PHE A 225 SITE 1 AC4 9 LYS A 77 ARG A 78 VAL A 79 PHE A 80 SITE 2 AC4 9 LEU A 101 PRO A 133 LEU A 221 PRO A 224 SITE 3 AC4 9 PHE A 225 CRYST1 95.747 95.747 82.407 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010444 0.006030 0.000000 0.00000 SCALE2 0.000000 0.012060 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012135 0.00000